Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib
Clinical trial NCT00688766 · TERMINATED
Trial details
- NCT number
- NCT00688766
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2009-05-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.